195 related articles for article (PubMed ID: 35356464)
41. An 11-lncRNA risk scoring model predicts prognosis of lung squamous cell carcinoma.
Liu JH; Xu YM; Yan J
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5456-5464. PubMed ID: 32495880
[TBL] [Abstract][Full Text] [Related]
42. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
43. Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma.
Lei K; Liang R; Tan B; Li L; Lyu Y; Wang K; Wang W; Wang K; Hu X; Wu D; Lin H; Wang M
Oxid Med Cell Longev; 2023; 2023():6811625. PubMed ID: 36703911
[TBL] [Abstract][Full Text] [Related]
44. Competitive Endogenous RNA Network Construction and Comparison of Lung Squamous Cell Carcinoma in Smokers and Nonsmokers.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang X; Li J; Li J; Sun C
Dis Markers; 2019; 2019():5292787. PubMed ID: 31885738
[TBL] [Abstract][Full Text] [Related]
45. Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patients.
Liu X; Zhao D; Shan Y; Cui W; Xie Q; Jiang J; Peng W; Zhang C; Duan C
Sci Rep; 2022 Dec; 12(1):20737. PubMed ID: 36456645
[TBL] [Abstract][Full Text] [Related]
46. Identification of Specific Candidate Diagnostic Biomarkers for Lung Squamous Cell Carcinoma Based on Methylation.
Wang X; Wang X; Li X; Chang Y
J Comput Biol; 2020 May; 27(5):825-833. PubMed ID: 31486674
[TBL] [Abstract][Full Text] [Related]
47. Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma.
Tang RX; Chen WJ; He RQ; Zeng JH; Liang L; Li SK; Ma J; Luo DZ; Chen G
Oncotarget; 2017 Aug; 8(31):50761-50773. PubMed ID: 28881601
[TBL] [Abstract][Full Text] [Related]
48. The development and validation of a m6A-lncRNAs based prognostic model for overall survival in lung squamous cell carcinoma.
Huang H; Wu W; Lu Y; Pan X
J Thorac Dis; 2022 Oct; 14(10):4055-4072. PubMed ID: 36389308
[TBL] [Abstract][Full Text] [Related]
49. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
Diao X; Guo C; Liu L; Wang G; Li S
Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
[TBL] [Abstract][Full Text] [Related]
50. Prediction of immune subtypes and overall survival in lung squamous cell carcinoma.
Su X; Gao H; Qi Z; Xu T; Wang G; Luo H; Cheng P
Curr Med Res Opin; 2023 Feb; 39(2):289-298. PubMed ID: 36245361
[TBL] [Abstract][Full Text] [Related]
51. A nomogram based on A-to-I RNA editing predicting overall survival of patients with lung squamous carcinoma.
Liu L; Liu J; Deng X; Tu L; Zhao Z; Xie C; Yang L
BMC Cancer; 2022 Jun; 22(1):715. PubMed ID: 35768804
[TBL] [Abstract][Full Text] [Related]
52. A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma.
Luo D; Deng B; Weng M; Luo Z; Nie X
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1207-1214. PubMed ID: 28835135
[TBL] [Abstract][Full Text] [Related]
53. A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma.
Huang G; Huang Q; Xie Z; Zhou H; Cao J; Shi L; Yang M
Cancer Biomark; 2019; 26(3):239-247. PubMed ID: 31524143
[TBL] [Abstract][Full Text] [Related]
54. SFTA1P, LINC00968, GATA6-AS1, TBX5-AS1, and FEZF1-AS1 are crucial long non-coding RNAs associated with the prognosis of lung squamous cell carcinoma.
Xiong Y; Zhang X; Lin Z; Xiong A; Xie S; Liang J; Zhang W
Oncol Lett; 2019 Oct; 18(4):3985-3993. PubMed ID: 31579094
[TBL] [Abstract][Full Text] [Related]
55. A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma.
Zhou W; Zhang W
BMC Cancer; 2022 Jun; 22(1):694. PubMed ID: 35739504
[TBL] [Abstract][Full Text] [Related]
56. The necroptosis signature and molecular mechanism of lung squamous cell carcinoma.
Song GQ; Wu HM; Ji KJ; He TL; Duan YM; Zhang JW; Hu GQ
Aging (Albany NY); 2023 Nov; 15(22):12907-12926. PubMed ID: 37976123
[TBL] [Abstract][Full Text] [Related]
57. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
Yang K; Wu Y
BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049
[TBL] [Abstract][Full Text] [Related]
58. Identification of Key DNA methylation sites related to differentially expressed genes in Lung squamous cell carcinoma.
Gao J; Feng Y; Yang Y; Shi Y; Liu J; Lin H; Zhang L
Comput Biol Med; 2023 Dec; 167():107615. PubMed ID: 37918267
[TBL] [Abstract][Full Text] [Related]
59. Systematic analysis identifies three-lncRNA signature as a potentially prognostic biomarker for lung squamous cell carcinoma using bioinformatics strategy.
Hu J; Xu L; Shou T; Chen Q
Transl Lung Cancer Res; 2019 Oct; 8(5):614-635. PubMed ID: 31737498
[TBL] [Abstract][Full Text] [Related]
60. A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma.
Yang Q; Gong H; Liu J; Ye M; Zou W; Li H
Sci Rep; 2022 Aug; 12(1):13646. PubMed ID: 35953696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
